TickerGuard
Buy Day today: Neutral (55) Mixed market breadth · no major macro event
PSNL

Personalis Inc

Healthcare · Diagnostics & Research

16.10$ +0.4% vs. previous close Closing price · As of: Oct 8, 2026

Statements

Balance Sheet

Personalis Inc (PSNL) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 312 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet PSNL
Line item Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
0.0 – – 42 58 192 160 157 152 146 249 245 396 383 407 397 381 358 318 293 272 249 227 225 195 186 240 270 273 259 243 334 325 312
23 – – 30 43 176 140 140 135 120 224 221 373 354 329 318 294 260 222 200 183 161 148 147 120 113 170 203 206 193 174 268 258 245
-23 – – 20 33 163 87 55 47 25 133 69 137 70 80 106 92 87 84 89 87 97 72 57 44 48 76 91 71 53 50 124 74 94
23 – – 20 33 163 127 128 120 105 206 203 353 329 305 287 267 233 193 168 149 137 121 114 95 87 144 185 186 173 151 240 233 213
0.0 – – 4.5 3.1 7.5 4.4 3.3 5.5 5.4 5.9 6.3 8.1 9.3 11 18 14 13 14 17 18 10 14 18 11 13 13 8.1 11 10.0 14 16 13 15
0.0 – – 2.1 2.2 1.6 2.0 1.4 3.9 3.3 2.6 2.7 2.0 4.2 3.8 4.1 4.8 6.5 5.9 6.4 5.5 4.8 8.2 5.7 5.0 4.7 6.3 4.0 4.2 4.6 3.7 6.1 6.9 9.6
0.0 – – – 14 15 17 16 15 24 23 12 11 25 18 20 31 48 61 62 61 59 75 – – – – – – – – – – –
0.0 – – – 0.0 – – – – – – – – – – – – – – – – – – – – – – – – – – – – –
0.0 – – – 0.0 – – – – – – – – – – – – – – – – – – – – – – – – – – – – –
0.0 – – 148 78 75 48 51 53 52 45 50 47 45 81 86 94 93 75 75 79 73 75 96 75 73 73 67 66 68 71 73 71 77
0.0 – – 58 58 56 47 50 52 43 36 41 39 34 27 31 40 42 34 33 34 29 32 47 31 34 36 31 30 32 36 40 39 46
0.0 – – 5.0 1.0 2.1 1.4 1.4 1.1 2.1 2.3 2.4 2.5 6.1 5.3 5.5 6.0 6.4 7.1 7.6 8.8 8.1 3.7 9.4 9.5 9.4 9.1 9.4 10 9.0 8.4 8.1 7.8 7.8
0.0 – – 6.6 8.0 8.8 7.8 7.3 10 7.5 6.5 8.3 6.5 8.9 7.3 9.2 12 21 11 13 11 8.8 9.0 15 9.2 9.9 12 6.4 7.9 9.9 11 13 13 16
0.0 – – – 20 18 – – – – – – – 1.6 1.7 – 1.7 – 0.4 – 0.4 0.4 – – – 0.7 0.4 – – – – – – –
-17 – – -106 -20 117 111 107 99 93 204 195 348 339 325 310 287 265 242 218 194 176 151 129 121 112 167 203 207 191 171 261 255 235
0.0 – – -116 -122 -127 -134 -141 -150 -159 -169 -182 -194 -209 -227 -247 -275 -303 -329 -360 -389 -413 -442 -469 -482 -494 -534 -550 -566 -586 -607 -631 -661 -693
22 22 22 22 28 30 31 31 31 32 35 35 42 44 45 45 45 46 46 46 47 48 49 49 51 52 61 73 87 89 89 92 104 105

Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?